B. Riley Financial’s Exagen XGN Stock Holding History

B. Riley Financial’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-50,000	Closed	-$349K	–	45
2025 Q2	$349K	Buy	+50,000	New	+$304K	0.39%	22

Other funds holding XGN

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

B. Riley Financial's XGN Position: Q3 2025 in Review

B. Riley Financial sold out of Exagen (XGN) in Q3 2025, closing a stake of 50,000 shares — an estimated $349K sold.

B. Riley Financial first reported a position in XGN in Q2 2025 and held it in 1 quarter. The position peaked at $349K in Q2 2025. 62 funds tracked by Wall St. Rank hold XGN as of Q3 2025.

B. Riley Financial reported no remaining Exagen position as of Q3 2025 after selling out during the quarter.
B. Riley Financial sold 50,000 Exagen shares in Q3 2025, an estimated $349K.
B. Riley Financial first reported a position in Exagen in Q2 2025 and held it in 1 quarter.
B. Riley Financial's Exagen position peaked at $349K in Q2 2025.
62 funds tracked by Wall St. Rank held Exagen as of Q3 2025.

Based on B. Riley Financial's 13F filing for Q3 2025, filed 3 Feb 2026.